Jamshed Kanga, MD

7/1/24 → 6/30/25

Project: Research project

Cystic Fibrosis Center Program FY25 - Pediatrics Portion

Kanga, J., Ramdial, F., Thomas, T. & Wurth, M.

7/1/24 → 6/30/25

Project: Research project

Applying the ORBIT Model to Address Medical Trauma in Youth with CF

Marsac, M., Kanga, J. & Wurth, M.

6/1/23 → 5/31/25

Project: Research project

A Prospective Study Evaluating Maternal and FetaL Outcomes in the ERa of ModulatorS (MAYFLOWERS)

Anstead, M., Kanga, J. & Danov, Z.

4/1/21 → 2/15/25

Project: Research project

Characterizing CFTR Modulated Changes in Sweat Chloride and Clinical Outcomes

Kanga, J. & Pancham, K.

7/1/17 → 10/19/24

Project: Research project

Finished

Cystic Fibrosis Center Program FY24 - Pediatrics Portion

Kanga, J., Ramdial, F., Thomas, T. & Wurth, M.

7/1/23 → 6/30/24

Project: Research project

Applying the ORBIT Model to Address Medical Trauma in Youth with CF

Marsac, M., Kanga, J. & Wurth, M.

6/1/23 → 5/31/24

Project: Research project

Cystic Fibrosis Center Program FY23 - Pediatrics Portion

Kanga, J., Danov, Z. & Wurth, M.

7/1/22 → 6/30/23

Project: Research project

FY23 Metabolic Newborn Screening

Zarate, Y., Day, S., Fowlkes, J., Kahler, S., Kanga, J., Radulescu, V. & Wurth, M.

7/1/22 → 6/30/23

Project: Research project

FY24 Metabolic Newborn Screening

Zarate, Y., Day, S., Fowlkes, J., Kahler, S., Kanga, J., Radulescu, V. & Wurth, M.

7/1/22 → 6/30/24

Project: Research project

Therapeutic Development Center FY23

Wurth, M., Anstead, M., Danov, Z., Kanga, J. & Kuhn, R.

4/1/22 → 3/31/23

Project: Research project

Therapeutic Development Center FY24

Wurth, M., Anstead, M., Kanga, J., Kuhn, R., Ramdial, F. & Danov, Z.

4/1/22 → 6/30/24

Project: Research project

Cystic Fibrosis Center Program FY22 - Pediatrics Portion

Kanga, J., Danov, Z. & Wurth, M.

7/1/21 → 6/30/22

Project: Research project

FY21 UK Metabolic Newborn Screening

Day, S., Kahler, S., Kanga, J., Radulescu, V., Thrailkill, K. & Wurth, M.

7/1/20 → 6/30/21

Project: Research project

FY22 UK Metabolic Newborn Screening

Day, S., Fowlkes, J., Kahler, S., Kanga, J., Radulescu, V. & Wurth, M.

7/1/20 → 6/30/22

Project: Research project

Cystic Fibrosis Center Program FY21 - Pediatrics Portion

Kanga, J., Danov, Z., Marsac, M., Pancham, K. & Wurth, M.

7/1/20 → 6/30/21

Project: Research project

FY20 Metabolic Newborn Screening

Psychogios, A., Fowlkes, J., Kanga, J., Radulescu, V. & Wurth, M.

7/1/18 → 6/30/20

Project: Research project

FY19 Metabolic Newborn Screening

Day, S., Fowlkes, J. & Kanga, J.

7/1/18 → 6/30/19

Project: Research project

Cystic Fibrosis Center Program 2016-2017

Kanga, J., Anstead, M., Danov, Z. & Pancham, K.

KY Department for Public Health

7/1/16 → 6/30/17

Project: Research project

Metabolic Newborn Screening - 2016

Amato, R., Kanga, J. & Thrailkill, K.

7/1/16 → 6/30/17

Project: Research project

FY18 Metabolic Newborn Screening

Amato, R., Kanga, J. & Thrailkill, K.

Nivalis Therapeutics Incorporated

7/1/16 → 6/30/18

Project: Research project

A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of N91115 to Evaluate Efficacy and Safety in Patients with Cystic Fibrosis who are Homozygous for the F508del-CFTR Mutation and Being Treated with lumacaftor/ivacaftor (ORKAMBI)

Anstead, M., Danov, Z., Kanga, J. & Tupayachi Ortiz, M.

9/30/15 → 8/30/17

Project: Research project

Cystic Fibrosis Center Program 2014-2015

7/1/15 → 6/30/16

Project: Research project

Cystic Fibrosis Center Program--2014-2015

7/1/14 → 6/30/15

Project: Research project

Metabolic Newborn Screening--FY 2015

Amato, R., Kanga, J. & Smith, W.

7/1/14 → 6/30/15

Project: Research project

Metabolic Newborn Screening

Amato, R., Kanga, J. & Thrailkill, K.

7/1/14 → 6/30/16

Project: Research project

Therapeutic Development Center FY2020

Pancham, K., Anstead, M., Danov, Z., Kanga, J. & Kuhn, R.

1/1/14 → 3/31/20

Project: Research project

Therapeutic Development Center FY2022

Wurth, M., Anstead, M., Danov, Z., Kanga, J. & Kuhn, R.

Cystic Fibrosis Foundation Therapeutics Incorporated

1/1/14 → 3/30/22

Project: Research project

Therapeutics Development Network 2014-2015

Anstead, M., Danov, Z., Kanga, J. & Kuhn, R.

1/1/14 → 12/31/15

Project: Research project

Therapeutic Development Center FY2021

Pancham, K., Anstead, M., Danov, Z., Kanga, J. & Kuhn, R.

1/1/14 → 3/31/21

Project: Research project

Proof of Principal Evaluation of IV Gallium Nitrate (Ganite) in Patients with Cystic Fibrosis

Pancham, K., Danov, Z., Kanga, J., Anstead, M. & Tupayachi Ortiz, M.

9/1/13 → 6/30/18

Project: Research project

The EPIC Observational Study: Effectiveness and Safety of Intermittent Antimicrobial Therapy for the Treatment of New Onset Pseudomonas Aeruginosa (Pa) Airway Infection in Young Patients with Cystic Fibrosis

Kanga, J.

9/1/13 → 1/28/19

Project: Research project

Cystic Fibrosis Center Program 2019-2020 (PEDS Portion)

Kanga, J., Danov, Z., Pancham, K. & Wurth, M.

7/1/13 → 6/30/19

Project: Research project

Cystic Fibrosis Center Program 2013-2014

7/1/13 → 6/30/14

Project: Research project

Cystic Fibrosis FY 20 - Pediatrics Portion

Kanga, J., Danov, Z., Pancham, K. & Wurth, M.

7/1/13 → 6/30/20

Project: Research project

Cystic Fibrosis Center Program 2017-2018

Kanga, J., Anstead, M., Danov, Z. & Pancham, K.

7/1/13 → 6/30/18

Project: Research project

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Lumacaftor in Combination with Ivacaftor in Subjects Aged 12 Years and Older With Cystic Fibrosis, omozygous for the F508del-CFTR Mutation

Vertex Pharmaceuticals Inc

6/20/13 → 6/30/15

Project: Research project

A phase 2, randomized, double blind, placebo-controlled study of AeroVanc for the treatment of persistent methicillin-resistant Staphylococcus aureus lung infection in cystic fibrosis patients (SAV005-02)

Danov, Z., Anstead, M. & Kanga, J.

Savara Incorporated

3/13/13 → 3/31/15

Project: Research project

KaloBios CF KB001A-05 A Phase 2, Randomized Double-Blind, Placebo-Controlled, Repeat-dose Study of KB001A in Subjects with Cystic Fibrosis Infected withPseudomonas Aeruginosa

Danov, Z., Anstead, M. & Kanga, J.

KaloBios Pharmaceuticals Incorporated

10/30/12 → 10/30/14

Project: Research project

A Long-Term Prospective Observational Safety Study of the Incidence of and Risk Factors for Fibrosing Colonopathy

Chiltern International Incorporated

10/22/12 → 9/30/20

Project: Research project

KaloBios Asthma Study KB003-04 Safety, Tolerability, and Efficacy

Anstead, M., Danov, Z., Kanga, J. & Khosravi, M.

10/1/12 → 9/30/14

Project: Research project

VX12-770-112 / A Phase 3, Two-Arm, Rollover Study to Evaluate the Safety of Long-Term Ivacaftor Treatment in Subjects 6 Years of Age and Older

Vertex Pharmaceuticals Inc

9/1/12 → 8/30/14

Project: Research project

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ivacaftor in Subjects with Cystic Fibrosis who have the R117H-CFTR Mutation

Vertex Pharmaceuticals Inc

7/2/12 → 6/30/14

Project: Research project

Cystic Fibrosis Center Program

7/1/12 → 6/30/13

Project: Research project

Metabolic Newborn Screening--FY 14

Amato, R. & Kanga, J.

7/1/12 → 6/30/14

Project: Research project

Metabolic Newborn Screening

Wallace, C., Hong-McAtee, I., Kanga, J. & Anstead, M.

7/1/12 → 6/30/13

Project: Research project

ALPINE Study

Danov, Z., Anstead, M. & Kanga, J.

Gilead Sciences Inc

11/4/11 → 11/3/13

Project: Research project

Cystic Fibrosis Center Progam

7/1/11 → 6/30/12

Project: Research project

Mpex 209 Study